title: Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right direction.
authors.affiliation: New York University Langone Medical Center New York, New York Komal.Jhaveri@nyumc.org.
authors.forename: Komal
authors.initials: K
authors.lastname: Jhaveri
authors.affiliation: University of Washington Seattle, Washington.
authors.forename: Hannah
authors.initials: H
authors.lastname: Linden
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism*; D006801:Humans; D049268:Positron-Emission Tomography; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D019788:Fluorodeoxyglucose F18; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human